These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30949987)

  • 1. Pentoxifylline, progression of chronic kidney disease (CKD) and cardiovascular mortality: long-term follow-up of a randomized clinical trial.
    de Morales AM; Goicoechea M; Verde E; Carbayo J; Barbieri D; Delgado A; Verdalles U; de Jose AP; Luño J
    J Nephrol; 2019 Aug; 32(4):581-587. PubMed ID: 30949987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.
    Goicoechea M; Garcia de Vinuesa S; Verdalles U; Verde E; Macias N; Santos A; Pérez de Jose A; Cedeño S; Linares T; Luño J
    Am J Kidney Dis; 2015 Apr; 65(4):543-9. PubMed ID: 25595565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).
    Goicoechea M; de Vinuesa SG; Quiroga B; Verde E; Bernis C; Morales E; Fernández-Juárez G; de Sequera P; Verdalles U; Delgado R; Torres A; Arroyo D; Abad S; Ortiz A; Luño J
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):255-263. PubMed ID: 29943364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pentoxifylline on inflammatory parameters in chronic kidney disease patients: a randomized trial.
    Goicoechea M; García de Vinuesa S; Quiroga B; Verdalles U; Barraca D; Yuste C; Panizo N; Verde E; Muñoz MA; Luño J
    J Nephrol; 2012; 25(6):969-75. PubMed ID: 22241639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis.
    Liu D; Wang LN; Li HX; Huang P; Qu LB; Chen FY
    J Int Med Res; 2017 Apr; 45(2):383-398. PubMed ID: 28415944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pentoxifylline in proteinuric chronic kidney disease: a systematic review and meta-analysis.
    Jiang X; Zhou S; Yao J; Kong X; Cui M
    J Nephrol; 2016 Oct; 29(5):653-62. PubMed ID: 26510426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis.
    Kuo KL; Hung SC; Liu JS; Chang YK; Hsu CC; Tarng DC
    Sci Rep; 2015 Nov; 5():17150. PubMed ID: 26612282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.
    Navarro-González JF; Muros M; Mora-Fernández C; Herrera H; Meneses B; García J
    J Diabetes Complications; 2011; 25(5):314-9. PubMed ID: 21144773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
    Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial.
    Navarro-González JF; Mora-Fernández C; Muros de Fuentes M; Chahin J; Méndez ML; Gallego E; Macía M; del Castillo N; Rivero A; Getino MA; García P; Jarque A; García J
    J Am Soc Nephrol; 2015 Jan; 26(1):220-9. PubMed ID: 24970885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pentoxifylline on renal outcomes in chronic kidney disease patients: A systematic review and meta-analysis.
    Leporini C; Pisano A; Russo E; D Arrigo G; de Sarro G; Coppolino G; Bolignano D
    Pharmacol Res; 2016 May; 107():315-332. PubMed ID: 26995301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney Disease.
    Wu PC; Wu CJ; Lin CJ; Pan CF; Chen CY; Huang TM; Wu CH; Lin SL; Chen YM; Chen L; Wu VC; ;
    Clin Pharmacol Ther; 2015 Oct; 98(4):442-9. PubMed ID: 26082272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease.
    Wanner C; Lachin JM; Inzucchi SE; Fitchett D; Mattheus M; George J; Woerle HJ; Broedl UC; von Eynatten M; Zinman B;
    Circulation; 2018 Jan; 137(2):119-129. PubMed ID: 28904068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of BP with Death, Cardiovascular Events, and Progression to Chronic Dialysis in Patients with Advanced Kidney Disease.
    Palit S; Chonchol M; Cheung AK; Kaufman J; Smits G; Kendrick J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):934-40. PubMed ID: 25979975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Bolignano D; D'Arrigo G; Pisano A; Coppolino G
    PLoS One; 2015; 10(8):e0134104. PubMed ID: 26237421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.
    Schulman G; Berl T; Beck GJ; Remuzzi G; Ritz E; Shimizu M; Kikuchi M; Shobu Y
    Clin Exp Nephrol; 2018 Apr; 22(2):299-308. PubMed ID: 28741050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease.
    Chen PM; Lai TS; Chen PY; Lai CF; Wu V; Chiang WC; Chen YM; Wu KD; Tsai TJ
    J Formos Med Assoc; 2014 Apr; 113(4):219-26. PubMed ID: 24512756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney Disease.
    Sabounjian L; Graham P; Wu L; Braman V; Cheng C; Liu J; Shipley J; Neutel J; Dao M
    Clin Pharmacol Drug Dev; 2016 Jul; 5(4):314-25. PubMed ID: 27310332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pentoxifylline on graft function of renal transplant recipients complicated with chronic allograft nephropathy.
    Shu KH; Wu MJ; Chen CH; Cheng CH; Lian JD; Lu YS
    Clin Nephrol; 2007 Mar; 67(3):157-63. PubMed ID: 17390740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.